Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73:17–48

Article  PubMed  Google Scholar 

Zahorec R (2001) Ratio of neutrophil to lymphocyte counts—rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 102:5–14

CAS  PubMed  Google Scholar 

Tomita M, Shimizu T, Ayabe T, Yonei A, Onitsuka T (2011) Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for non-small cell lung cancer. Anticancer Res 31:2995–2998

PubMed  Google Scholar 

Forget P, Machiels JP, Coulie PG, Berliere M, Poncelet AJ, Tombal B et al (2013) Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery. Ann Surg Oncol 3:650–660

Article  Google Scholar 

Shimizu K, Okita R, Saisho S, Maeda A, Nojima Y, Nakata M (2015) Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer. World J Surg Oncol 13:291

Article  PubMed  PubMed Central  Google Scholar 

Motono N, Mizoguchi T, Ishikawa M, Iwai S, Iijima Y, Hidetaka U (2022) Prognostic value of neutrophil-to-lymphocyte ratio and prognostic nutrition index in patients with non-small cell lung cancer receiving pulmonary resection. World J Surg Res 5:1401

Google Scholar 

Su YL, Tsai KL, Chiu TJ, Lin YM, Lee KC, Lu CC et al (2021) Development and validation of a novel serum prognostic marker for patients with metastatic colorectal cancer on regorafenib treatment. Cancers 13:5080

Article  CAS  PubMed  PubMed Central  Google Scholar 

You JF, Hsu YJ, Chern YJ, Cheng CC, Jong BK, Liao CK et al (2022) Preoperative cancer inflammation prognostic index as a superior predictor of short- and long-term outcomes in patients with stage I-III colorectal cancer after curative surgery. Cancers 14:6232

Article  PubMed  PubMed Central  Google Scholar 

Grunnet M, Sorensen JB (2012) Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer 76:138–143

Article  CAS  PubMed  Google Scholar 

Brinkman GL, Coates EO (1963) The effect of bronchitis, smoking, and occupation on ventilation. Am Rev Respir Dis 87:684–693

CAS  PubMed  Google Scholar 

Li D, Yuan X, Liu J, Li C, Li W (2018) Prognostic value of prognostic nutritional index in lung cancer: a meta-analysis. J Thorac Dis 10:5298–5307

Article  PubMed  PubMed Central  Google Scholar 

Qiu C, Qu X, Shen X, Zheng C, Zhu L, Meng L et al (2015) Evaluation of prognostic nutritional index in patients undergoing radical surgery with nonsmall cell lung cancer. Nutr Cancer 67:741–747

Article  PubMed  Google Scholar 

Kim YS, Kim SJ, Kim TK, Kim IJ, Kim YD, Lee MK (2011) Prediction of survival and cancer recurrence using F-18 FDG PET/CT in patients with surgically resected early stage (Stage I and II) non-small cell lung cancer. Neoplasma 58:245–250

Article  CAS  PubMed  Google Scholar 

Nitadori J, Bograd AJ, Morales EA, Rizk NP, Dunphy MPS, Sima CS et al (2013) Preoperative consolidation-to-tumor ratio and SUVmax stratify the risk of recurrence in patients undergoing limited resection for lung adenocarcinoma ≤2cm. Ann Surg Oncol 20:4282–4288

Article  PubMed  PubMed Central  Google Scholar 

Motono N, Ueno M, Tanaka M, Machida Y, Usuda K, Sakuma T et al (2014) Differences in the prognostic significance of the SUVmax between patients with resected pulmonary adenocarcinoma and squamous cell carcinoma. Asian Pac J Cancer Prev 15:10171–10174

Article  PubMed  Google Scholar 

Felip E, Altorki N, Zhou C, Csőszi T, Vynnychenko I, Goloborodko O et al (2021) Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial. Lancet 398:1344–1357

Article  CAS  PubMed  Google Scholar 

Wu YL, John T, Grohe C, Majem M, Goldman JW, Kim SW et al (2021) Postoperative chemotherapy use and outcomes from ADAURA: osimertinib as adjuvant therapy for resected EGFR-mutated NSCLC. J Thorac Oncol 17:423–433

Article  PubMed  Google Scholar 

Kato H, Ichinose Y, Ohta M, Hata E, Tsubota N, Tada H et al (2004) A randomized trial of adjuvant chemotherapy with uracil-tagafur for adenocarcinoma for the lung. N Engl J Med 350:1713–1721

Article  CAS  PubMed  Google Scholar 

Tsutani Y, Imai K, Ito H, Miyata Y, Ikeda N, Nakayama H et al (2022) Adjuvant chemotherapy for high-risk pathologic stage I non-small cell lung cancer. Ann Thorac Surg 113:1608–2161

Article  PubMed  Google Scholar 

Rizzo A, Cantale O, Mogavero A, Garetto L, Racca M, Venesio T et al (2023) Assessing the role of colonic and other anatomical sites uptake by [18F]FDG-PET/CT and immune-inflammatory peripheral blood indexes in patients with advanced non-small cell lung cancer treated with first-line immune checkpoint inhibitors. Thorac Cancer 14:2473–2483

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cvetkovic L, Régis C, Richard C, Derosa L, Leblond A, Malo J et al (2021) Physiologic colonic uptake of 18F-FDG on PET/CT is associated with clinical response and gut microbiome composition in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors. Eur J Nucl Med Mol Imaging 48:1550–1559

Article  CAS  PubMed  Google Scholar